Scientists try to 'Wake Up' immune system to fight tough colon cancers
NCT ID NCT02512172
Summary
This study tested whether adding one or two 'epigenetic' drugs could help a cancer immunotherapy (MK-3475) work for people with a hard-to-treat type of advanced colorectal cancer. It involved 27 patients whose cancer had stopped responding to standard treatments. The main goals were to see if the drug combinations were safe and if they could change the immune cells inside the tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.